Systemic mast cell disease (SMCD) and bone pain - A case treated with radiotherapy

被引:4
|
作者
Hesselmann, S [1 ]
Micke, O [1 ]
Schaefer, U [1 ]
Willich, N [1 ]
机构
[1] Univ Hosp Muenster, Dept Radiotherapy & Radiooncol, Munster, Germany
关键词
systemic mast cell disease; SMCD; bone pain; radiotherapy;
D O I
10.1007/s00066-002-0928-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Systemic mast cell disease (SMCD) is a rare disease characterized by a multitopic proliferation of cytologically and/or functionally abnormal tissue mast cells. SMCD preferentially involves the skin, spleen, Liver, lymph nodes and the bone marrow. The cause of SMCD is unknown. Bony pain, caused by mast cell infiltration of the marrow cavity, is present in up to 28% of cases and is frequently chronic and difficult to palliate with medical therapy. Case Report: We report one case of refractory bone pain in a 54-year-old female Caucasian patient with advanced SMCD and associated bony involvement, which was treated with radiotherapy for pain palliation. Between 1995 and 1998, the patient was irradiated at four different locations: 1) right shoulder and proximal right humerus, 2) both hands, 3) both knees, 4) left humerus with a total dose of 40 Gy in 2.0 or 2.5 Gy daily fractions. Results: Different results of pain palliation were achieved. In one location the pain was reduced for 55 months until her death due to disease progression, whereas in two other Locations a pain control was maintained for 3 and 6 months after radiotherapy. In one Location, no pain reduction was achieved. Severe side effects were not observed. Conclusion: Palliative radiotherapy has a role in the control of severe intractable bone pain in patients with advanced SMCD, though in some cases the effect may be short or incomplete. The observed palliation of pain can even differ in the same patient.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 50 条
  • [31] SYSTEMIC MAST-CELL DISEASE (MASTOCYTOSIS)
    REMY, D
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1957, 82 (18) : 719 - 722
  • [32] HEPARIN EFFECTS IN SYSTEMIC MAST CELL DISEASE
    MCMILLAN, CW
    FALLON, HJ
    ZEPPA, R
    JOURNAL OF PEDIATRICS, 1966, 69 (5P2): : 976 - +
  • [33] Indolent systemic mast cell disease in adults:: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
    Escribano, L
    Orfao, A
    Díaz-Agustin, B
    Villarrubia, J
    Cerveró, C
    López, A
    Marcos, MAG
    Bellas, C
    Fernández-Cañadas, S
    Cuevas, M
    Sánchez, A
    Velasco, JL
    Navarro, JL
    San Miguel, JF
    BLOOD, 1998, 91 (08) : 2731 - 2736
  • [34] Bone marrow microvessel density and angiogenic cytokine immunohistochemistry in systemic mast cell disease.
    Baek, JY
    Li, CY
    Pardanani, A
    Tefferi, A
    BLOOD, 2001, 98 (11) : 630A - 631A
  • [35] A common presentation of an uncommon disease - systemic mast cell disease
    Gabrielly, M
    Habib, GS
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (05): : 388 - 388
  • [36] Systemic mast cell disease associated with hairy cell leukaemia
    Petrella, T
    Depret, O
    Arnould, L
    Maynadie, M
    Guy, H
    Dalac, S
    Caillot, D
    Casasnovas, O
    Lombard, JN
    LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 593 - 595
  • [37] A near-haploid bone marrow karyotype in systemic mast cell disease: Is it characteristic of the disease or an incidental finding?
    Shekhter-Levin, S
    Ball, E
    Swerdlow, SH
    Li, WV
    Kapadia, SB
    Sherer, ME
    Wald, N
    Gollin, SM
    CANCER GENETICS AND CYTOGENETICS, 1998, 103 (02) : 124 - 129
  • [38] Evaluation of Mast Cell Disease in Women: A Case Study of Delayed Diagnosis of Systemic Mastocytosis
    Hatcher, Vishaka R.
    Alix, Veronica C.
    Hellu, Tasha S.
    Schuldt, Meredith M.
    Adams, Karla E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (03): : 680 - 682
  • [39] Treatment of systemic mast cell disease: beyond interferon
    Tefferi, A
    LEUKEMIA RESEARCH, 2004, 28 (03) : 223 - 224
  • [40] Therapy of systemic mast cell disease - a pharmacotherapeutical challenge
    Molderings, G. J.
    Taumann, W.
    Brettner, S.
    Homann, J.
    Menzen, M.
    Dumoulin, F. L.
    Panse, J.
    Haenisch, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S67 - S67